Compugen Ltd (CGEN): Capital Expenditures
$306.0K
Year ended 2025-12-31
-13.8%
3-year compound annual growth
+13.0%
5-year compound annual growth
-20.7%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $306.0K | +159.3% | 2026-03-02, From 2025-01-01 |
| 2024-12-31 | $118.0K | -31.4% | 2026-03-02, From 2024-01-01 |
| 2023-12-31 | $172.0K | -63.9% | 2026-03-02, From 2023-01-01 |
| 2022-12-31 | $477.0K | +63.4% | 2025-03-04, From 2022-01-01 |
| 2021-12-31 | $292.0K | +75.9% | 2024-03-05, From 2021-01-01 |
| 2020-12-31 | $166.0K | +7.1% | 2023-08-23, From 2020-01-01 |
| 2019-12-31 | $155.0K | -1.9% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $158.0K | -59.0% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $385.0K | -85.2% | 2020-02-24, From 2017-01-01 |
| 2016-12-31 | $2.60M | -16.7% | 2019-03-21, From 2016-01-01 |
| 2015-12-31 | $3.12M | +64.6% | 2018-03-27, From 2015-01-01 |
| 2014-12-31 | $1.90M | +478.0% | 2017-02-16, From 2014-01-01 |
| 2013-12-31 | $328.0K | -67.4% | 2016-03-07, From 2013-01-01 |
| 2012-12-31 | $1.00M | +946.9% | 2015-03-12, From 2012-01-01 |
| 2011-12-31 | $96.0K | +108.7% | 2014-02-18, From 2011-01-01 |
| 2010-12-31 | $46.0K | -4.2% | 2013-03-21, From 2010-01-01 |
| 2009-12-31 | $48.0K | n/a | 2012-03-14, From 2009-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Compugen Ltd (CGEN) | 2025-12-31 | $306.0K | +159.3% |
| Recursion Pharmaceuticals, Inc. (RXRX) | 2025-12-31 | $6.47M | -52.8% |
| Autolus Therapeutics plc (AUTL) | 2025-12-31 | $19.04M | -13.7% |
| Black Diamond Therapeutics, Inc. (BDTX) | 2024-12-31 | $0 | -100.0% |
| Vir Biotechnology, Inc. (VIR) | 2025-12-31 | $4.83M | -33.8% |
| MeiraGTx Holdings plc (MGTX) | 2025-12-31 | $3.83M | -22.8% |
| 4D Molecular Therapeutics, Inc. (FDMT) | 2025-12-31 | $536.0K | -85.8% |
| Champions Oncology, Inc. (CSBR) | 2026-04-30 | $564.0K | +45.0% |
| Invivyd, Inc. (IVVD) | 2025-12-31 | $155.0K | +10.7% |
Compare CGEN, RXRX, AUTL, BDTX side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗